menu
    • menu

    Company profile for ReviR Therapeutics

    NEW Drugs in Dev: 2
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    ReviR Therapeutics is a research and development company aiming to treat human diseases by harnessing advanced AI technologies and RNA biology. Our AI-based platform allows us to explore beyond the protein-based target space to reach a large number of known disease targets previously considered "undruggable". Invent and build technologies to unlock first-in-class medicines for the treatment of cancer, rare genetic disorders, a...
    ReviR Therapeutics is a research and development company aiming to treat human diseases by harnessing advanced AI technologies and RNA biology. Our AI-based platform allows us to explore beyond the protein-based target space to reach a large number of known disease targets previously considered "undruggable". Invent and build technologies to unlock first-in-class medicines for the treatment of cancer, rare genetic disorders, and infectious diseases * Decipher disease relevant structural and functional RNA motifs by integrating human genetic data, functional genomics, and AI

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    ReviR TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    600 Gateway Blvd, 100A, South San Francisco, California 94080
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://revirtx.com/home
    Linkedin
    Linkedin
    https://www.linkedin.com/company/revir-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ReviR Doses First in Ph1, Gains CDE Orphan Nod
    ReviR Doses First in Ph1, Gains CDE Orphan Nod

    02 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revir-therapeutics-announces-first-participant-dosed-in-phase-1-study-and-secures-cde-clearance-for-two-orphan-indications-in-china-supporting-future-us-expansion-strategy-302701040.html

    PR NEWSWIRE
    02 Mar 2026
    Share Share
    Revir Therapeutics Gets $4.6M CIRM Grant For Huntington Disease
    Revir Therapeutics Gets $4.6M CIRM Grant For Huntington Disease

    20 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revir-therapeutics-receives-4-6-million-cirm-grant-to-advance-huntingtons-disease-treatment-and-announces-key-development-milestone-302621485.html

    PR NEWSWIRE
    20 Nov 2025
    Share Share
    FDA Grants Orphan Drug Designation To Revir Pharma's RTX-117
    FDA Grants Orphan Drug Designation To Revir Pharma's RTX-117

    13 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revir-therapeutics-receives-orphan-drug-designation-from-fda-for-rtx-117-to-treat-charcot-marie-tooth-disease-302581596.html

    PR NEWSWIRE
    13 Oct 2025
    Share Share
    ReviR, Kennedy's Disease Association Partner on Rare Neuro Disorder
    ReviR, Kennedy's Disease Association Partner on Rare Neuro Disorder

    25 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revir-therapeutics-and-kennedys-disease-association-partner-to-advance-treatment-for-rare-neuromuscular-disorder-302315214.html

    PR NEWSWIRE
    25 Nov 2024
    Share Share
    ReviR Therapeutics Secures $30M For CNS Disorder Genetic Medicines
    ReviR Therapeutics Secures $30M For CNS Disorder Genetic Medicines

    26 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/revir-therapeutics-raises-30-million-series-a-financing-to-advance-its-proprietary-oral-genetic-medicines-for-multiple-cns-disorders-302206560.html

    PR NEWSWIRE
    26 Jul 2024
    Share Share
    CMT partners with ReviR Research to advance small molecule therapeutics
    CMT partners with ReviR Research to advance small molecule therapeutics

    21 Jun 2024

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=169877&sid=2

    PHARMABIZ
    21 Jun 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search